DIN 02528908 — WELIREG 40 MG
WELIREG is a tablet of Belzutifan marketed by MERCK CANADA INC. The full Belzutifan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02528908
- Brand name
- WELIREG
- Active ingredient
- Belzutifan
- Strength
- 40 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- MERCK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- HIF-2 alpha inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.